MedPath

eurofeedback in the treatment of Attention Deficit Hyperactivity Disorder

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder.
Disturbance of activity and attention
Registration Number
IRCT138804132000N2
Lead Sponsor
Behavioral Sciences Research center, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

1-Diagnosis of ADHD based on DSM-IV-TR criteria by child and adolescent psychiatrists; 2- age of 7- 18 years; 3- IQ above 85 based on WISC-III-R; 4- parent consent for the participation in the study. Exclusion criteria: 1- neurological disorders; 2- major learning problems; 3- request of parent to exit from the study; 4- use of antipsychotic drugs in the month before the initiation of the study; 5- history of neurofeedback intervention at least for 10 sessions.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADHD symptoms. Timepoint: 1 week before the initiation and each monththrough the study and 1 week after the end of the intervention. Method of measurement: conners ADHD rating scale.
Secondary Outcome Measures
NameTimeMethod
Attention. Timepoint: 1 week before , and 1 week after the end of the trial. Method of measurement: Test of Variables of Attention.
© Copyright 2025. All Rights Reserved by MedPath